Literature DB >> 169876

Homonymous hemianopia in multiple sclerosis. With report of bilateral case.

K Hawkins, M M Behrens.   

Abstract

A patient with multiple sclerosis and bilateral retrochiasmal visual field defects is reported. Homonymous field defects are rare in multiple sclerosis despite the frequency of pathological involvement of the retrochiasmal visual pathways. A higher incidence might be found with a higher index of suspicion and careful visual field testing with qualitative confrontation technique. Other reasons for the infrequent clinical detection of retrochiasmal lesions are considered. Such lesions may exist without demonstrable defect. This may be explained by anatomical factors, for example, fibre arrangement, or physiological factors, such as, geniculate or retrogeniculate integration. Lesions producing demonstrable defects may be asymptomatic because they: affect only the peripheral field, are small scotomas that do not impair visual acuity, affect only one eye, or occur late in the course of disease when masked by optic nerve involvement.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 169876      PMCID: PMC1042631          DOI: 10.1136/bjo.59.6.334

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  17 in total

1.  Retrochiasmal visual field defects from multiple sclerosis.

Authors:  H A BOLDT; A F HAERER; W W TOURTELLOTTE; J W HENDERSON; R M DEJONG
Journal:  Arch Neurol       Date:  1963-05

2.  Optic tract neuritis in multiple sclerosis.

Authors:  N VEDEL-JENSEN
Journal:  Acta Ophthalmol (Copenh)       Date:  1959

3.  Integrative action in the cat's lateral geniculate body.

Authors:  D H HUBEL; T N WIESEL
Journal:  J Physiol       Date:  1961-02       Impact factor: 5.182

4.  Ocular Manifestations of Multiple Sclerosis and Relationship to Retrobulbar Neuritis.

Authors:  D Marshall
Journal:  Trans Am Ophthalmol Soc       Date:  1950

5.  Retrobulbar neuritis in multiple sclerosis.

Authors:  P J LEINFELDER
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1950

6.  The ocular findings in multiple sclerosis.

Authors:  N SAVITSKY; L RANGELL
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1950

7.  The course of multiple sclerosis as determined by autopsy proven cases.

Authors:  S CARTER; D SCIARRA; H H MERRITT
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1950

8.  Slowly progressive and acute visual impairment in multiple sclerosis.

Authors:  E Kahana; U Leibowitz; N Fishback; M Alter
Journal:  Neurology       Date:  1973-07       Impact factor: 9.910

9.  Demyelination and remyelination after acute spinal cord compression.

Authors:  R F Gledhill; B M Harrison; W I McDonald
Journal:  Exp Neurol       Date:  1973-03       Impact factor: 5.330

10.  A versatile color confrontation test for the central visual field. A comparison with quantitative perimetry.

Authors:  L Frisén
Journal:  Arch Ophthalmol       Date:  1973-01
View more
  4 in total

1.  Visual pattern evoked responses and blink reflexes in assessment of MS diagnosis. A clinical study of 135 multiple sclerosis/pathol.

Authors:  K Lowitzsch; U Kuhnt; C Sakmann; K Maurer; H C Hopf; D Schott; K Thäter
Journal:  J Neurol       Date:  1976-07-15       Impact factor: 4.849

2.  Bilateral homonymous visual field defects as initial manifestation of multiple sclerosis.

Authors:  B Sanchez-Dalmau; F J Goñi; M Guarro; C Roig; F Duch-Bordas
Journal:  Br J Ophthalmol       Date:  1991-03       Impact factor: 4.638

3.  Masquerading optic neuritis.

Authors:  Katherine McVeigh; Georgios Vakros; Rafik Girgis
Journal:  BMJ Case Rep       Date:  2015-08-03

4.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.

Authors:  C F Lucchinetti; R H Gavrilova; I Metz; J E Parisi; B W Scheithauer; S Weigand; K Thomsen; J Mandrekar; A Altintas; B J Erickson; F König; C Giannini; H Lassmann; L Linbo; S J Pittock; W Brück
Journal:  Brain       Date:  2008-06-05       Impact factor: 13.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.